- Home
- EFOI vs NEUP Comparison
EFOI vs NEUP Comparison
Compare EFOI & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFOI
- NEUP
- Stock Information
- Founded
- EFOI 1985
- NEUP 1996
- Country
- EFOI United States
- NEUP United States
- Employees
- EFOI N/A
- NEUP N/A
- Industry
- EFOI Building Products
- NEUP
- Sector
- EFOI Consumer Discretionary
- NEUP
- Exchange
- EFOI Nasdaq
- NEUP Nasdaq
- Market Cap
- EFOI 12.1M
- NEUP 12.7M
- IPO Year
- EFOI 1994
- NEUP N/A
- Fundamental
- Price
- EFOI $2.30
- NEUP $7.13
- Analyst Decision
- EFOI
- NEUP Strong Buy
- Analyst Count
- EFOI 0
- NEUP 1
- Target Price
- EFOI N/A
- NEUP $21.00
- AVG Volume (30 Days)
- EFOI 22.4K
- NEUP 26.7K
- Earning Date
- EFOI 08-12-2025
- NEUP 08-15-2025
- Dividend Yield
- EFOI N/A
- NEUP N/A
- EPS Growth
- EFOI N/A
- NEUP N/A
- EPS
- EFOI N/A
- NEUP 0.00
- Revenue
- EFOI $4,643,000.00
- NEUP $15,662,715.00
- Revenue This Year
- EFOI N/A
- NEUP N/A
- Revenue Next Year
- EFOI N/A
- NEUP N/A
- P/E Ratio
- EFOI N/A
- NEUP $2.30
- Revenue Growth
- EFOI N/A
- NEUP N/A
- 52 Week Low
- EFOI $1.14
- NEUP $2.90
- 52 Week High
- EFOI $2.95
- NEUP $126.00
- Technical
- Relative Strength Index (RSI)
- EFOI 59.77
- NEUP N/A
- Support Level
- EFOI $2.21
- NEUP N/A
- Resistance Level
- EFOI $2.37
- NEUP N/A
- Average True Range (ATR)
- EFOI 0.21
- NEUP 0.00
- MACD
- EFOI 0.04
- NEUP 0.00
- Stochastic Oscillator
- EFOI 78.57
- NEUP 0.00
About EFOI Energy Focus Inc.
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.